Cannabidiol's Role in Dementia Management

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Dementia, VascularDementia, Mixed
Interventions
DRUG

Cannabidiol Oil

The study intervention involves the administration of high purity Cannabidiol (CBD) in vegan soft gel capsule form. Dosing will range between 200 mg and 400 mg and will be administered twice daily. The CBD capsule is water-soluble to improve its bioavailability and absorption in the body.

Trial Locations (1)

43400

Hospital Sultan Abdul Aziz Shah, Serdang

All Listed Sponsors
collaborator

UPM Consultancy & Services Sdn. Bhd.

UNKNOWN

collaborator

Pure Life Collective Pte Ltd

UNKNOWN

lead

Hospital Pengajar Universiti Putra Malaysia

OTHER

NCT06514066 - Cannabidiol's Role in Dementia Management | Biotech Hunter | Biotech Hunter